Valuation: Baxter International Inc.

Market Cap 13.33B 12.15B 11.24B 10.14B 19.1B 1,245B 19.85B 136B 53.65B 672B 50B 48.95B 2,123B P/E 2026 *
20.8x
P/E 2027 * 18.8x
Enterprise Value 20.16B 18.38B 17B 15.34B 28.89B 1,884B 30.03B 205B 81.14B 1,017B 75.62B 74.04B 3,210B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.63x
Free-Float
75.44%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day+2.37%
1 week+0.11%
Current month+14.65%
1 month+5.52%
3 months+1.66%
6 months+48.23%
Current year+37.99%
1 week 25.12
Extreme 25.12
26.66
1 month 22.5
Extreme 22.495
27.08
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Chief Tech/Sci/R&D Officer 57 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Director/Board Member 69 15/02/2021
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

EVP and CFO

0 0.0000% -
02/09/26 Tax

President, Front Line Care

-2,098 0.0004%
02/09/26 Tax

Chief Executive Officer

-54,276 0.0105%
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%+0.11%+45.29%-25.97% 13.33B
-0.04%-4.11%-19.38%+3.56% 181B
-1.28%-0.42%+0.38%+34.63% 125B
+0.70%+0.29%-11.07%+10.52% 121B
+1.12%-0.96%-41.94%+2.39% 90.52B
-0.35%-0.27%-3.51%+78.09% 66.9B
+0.16%+0.62%+12.23%-7.63% 58.68B
+1.97%-0.01%+4.82%+48.54% 54.38B
+0.86%-0.15%-1.84%+38.65% 48.46B
+0.84%+4.77%+3.97%-1.08% 35.4B
Average +0.64%-0.77%-1.11%+18.17% 80B
Weighted average by Cap. +0.28%-1.54%-9.06%+19.34%

Financials

2026 *2027 *
Net sales 11.72B 10.69B 9.89B 8.92B 16.8B 1,096B 17.47B 119B 47.2B 591B 43.99B 43.06B 1,867B 11.96B 10.91B 10.09B 9.1B 17.14B 1,118B 17.82B 122B 48.15B 603B 44.87B 43.93B 1,905B
Net income 621M 566M 524M 472M 890M 58.02B 925M 6.32B 2.5B 31.32B 2.33B 2.28B 98.89B 601M 548M 507M 458M 862M 56.19B 896M 6.12B 2.42B 30.33B 2.26B 2.21B 95.77B
Net Debt 6.83B 6.23B 5.76B 5.2B 9.79B 638B 10.17B 69.56B 27.49B 344B 25.62B 25.09B 1,088B 6.14B 5.6B 5.18B 4.68B 8.81B 574B 9.15B 62.57B 24.73B 310B 23.05B 22.57B 979B
Projected Income Statement - Annual - Baxter International Inc.
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
18/11/26 $26.38 +2.39% 1,462,089
17/11/26 $25.76 +0.86% 4,165,062
16/11/26 $25.54 -1.05% 6,159,844
13/11/26 $25.81 +0.27% 4,491,217
12/11/26 $25.74 -2.28% 4,668,666
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Baxter International Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
25.76USD
Average target price
27.25USD
Spread / Average Target
+5.78%